DO-EUN LEE
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism NAPA, CA NPI 1346339652
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CA Amgen Inc. All categories
General Payments — all program years on this page
$90,597.29
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,289
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $11,069.04 across 125 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,824.00 | 1 |
| Food and Beverage | $2,611.76 | 118 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,010.00 | 1 |
| Travel and Lodging | $1,613.26 | 4 |
| Education | $10.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $8,864.87 | 26 |
| Lilly USA, LLC | $656.46 | 28 |
| Antares Pharma, Inc. | $222.98 | 12 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $203.51 | 8 |
| Novo Nordisk AS | $193.95 | 18 |
| Corcept Therapeutics | $146.37 | 3 |
| Alexion Pharmaceuticals, Inc. | $135.40 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $121.94 | 5 |
| Acerta Pharma LLC | $114.10 | 1 |
| Xeris Pharmaceuticals, Inc. | $68.86 | 3 |
| IBSA Pharma Inc. | $60.48 | 3 |
| Radius Health, Inc. | $55.57 | 2 |
| BETA BIONICS, INC. | $50.06 | 2 |
| Astellas Pharma US Inc | $49.98 | 3 |
| SANOFI-AVENTIS U.S. LLC | $36.41 | 2 |
| ABBVIE INC. | $26.70 | 1 |
| Daiichi Sankyo Inc. | $24.07 | 1 |
| GENZYME CORPORATION | $23.53 | 1 |
| Nevro Corp. | $13.80 | 1 |
By program year
Records — PY2024 (125)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.